Is Mercury Laboratories Ltd (538964) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Mercury Laboratories Ltd is a average quality company .

Is Mercury Laboratories Ltd (538964) undervalued or overvalued?

The key valuation ratios of Mercury Laboratories Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Mercury Laboratories Ltd (538964) share price return in the past 10 years?

Mercury Laboratories Ltd share price has appreciated 6.3% annually (CAGR) over the past ten years.

Is Mercury Laboratories Ltd (538964) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Mercury Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Mercury Laboratories Ltd (538964)?

Company share prices are keep on changing according to the market conditions. The current trading price of Mercury Laboratories Ltd (538964) on 16-Apr-2026 16:59:59 at 16:59 is 756.05.

What is the P/E ratio of Mercury Laboratories?

The latest standalone P/E ratio of Mercury Laboratories as of 16-Apr-2026 is 19.23.

What is the P/B ratio of Mercury Laboratories Ltd (538964)?

The latest standalone P/B ratio of Mercury Laboratories Ltd (538964) as of 16-Apr-2026 is 1.60.

What is the 52-week high and low of Mercury Laboratories Ltd (538964)?

The 52-week high of Mercury Laboratories Ltd (538964) is Rs. 976.00 and the 52-week low is Rs. 700.00.

Mercury Laboratories Ltd (538964) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Mercury Laboratories Ltd (538964)
Brand: Mercury Laboratories

Mercury Laboratories Ltd (538964) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Mercury Laboratories Ltd (538964)

BSE: 538964 NSE:

Key Metrics

Market Cap

₹91 Cr.

P/E Ratio

19.23

Price to Book (P/B)

1.60

Price to Sales (P/S)

1.19

EV/EBITDA

8.74

Return on Capital Employed (ROCE)

9.14%

Current Price

₹756.1

Return on Equity (ROE)

6.02%

Return on Assets (ROA)

4.42%

Operating Profit Margin

9.3%

Net Profit Margin

4.19%

Gross Profit Margin

10%

Book Value per Share

₹473

Sales Growth (YoY)

-0.61%

Sales Growth (3 Years)

9.04%

Operating Profit Growth (1 Year)

-22.26%

Operating Profit Growth (3 Years)

0.14%

Net Profit Growth (1 Year)

-44.42%

52-Week Low / High

₹700 / 976

Net Profit Growth (3 Years)

-4.07%

Dividend Yield

0.43%

Promoter Holding

73.66%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Mercury Laboratories Ltd?

Mercury Laboratories Ltd revenue growth is -0.6% for FY-2025 , which is below its 5 year CAGR of 5.6% , indicating slower growth.

Q.1 Promoter shareholding and pledge status of Mercury Laboratories Ltd?

Promoters hold 73.66% of the Mercury Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Mercury Laboratories Ltd vs industry peers?

Mercury Laboratories Ltd revenue CAGR is 5.57% , compared to the industry median CAGR of 5.54% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Mercury Laboratories Ltd belong to?

Mercury Laboratories Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Stock return of Mercury Laboratories Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 5.8% based on the current price.

DeciZen - make an informed investing decision on Mercury Laboratories

Based on:

Data

M-Cap below 100cr DeciZen not available

Mercury Laboratories stock performance

Key Ratios

Is Mercury Laboratories Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	21.6%	18.9%	9.9%	13.8%	13.3%	20.6%	12.3%	16.2%	13.6%	9.1%	-
Value Creation Index ⓘ	0.5	0.4	-0.3	0.0	-0.1	0.5	-0.1	0.2	0.0	-0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	47.5	48	51.9	55.5	57.3	68.6	57.9	75.3	75.6	75.1	76
Sales YoY Gr.	-	1.1%	8%	7%	3.2%	19.8%	-15.6%	30.1%	0.3%	-0.6%	-
Adj EPS ⓘ	30.3	23.6	16.8	20.7	26.2	42.9	26.3	39.3	44.7	23.3	39.3
YoY Gr.	-	-22.3%	-28.7%	23.2%	26.5%	63.6%	-38.7%	49.3%	13.7%	-47.8%	-
BVPS (₹) ⓘ	182.1	203.9	219.6	241.4	266.5	307.5	335.9	380.2	423.7	446.4	473
Adj Net Profit ⓘ	3.6	2.8	2	2.5	3.1	5.1	3.2	4.7	5.4	2.8	5
Cash Flow from Ops. ⓘ	-0.1	1.9	5	5.2	5.5	8.2	5.2	2.5	8.2	4	-
Debt/CF from Ops. ⓘ	-76	3.9	2	1.8	1.3	0.9	1	2.2	0.7	1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5.2%	5.6%	9%	-0.6%
Adj EPS ⓘ	-2.9%	-2.3%	-3.9%	-47.8%
BVPSⓘ	10.5%	10.9%	10%	5.4%
Share Price	6.3%	5.7%	5.7%	-10%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	18.2	12.2	7.9	9	10.3	14.9	8.2	11	11.1	5.4	8.6
Op. Profit Mgn % ⓘ	13.6	14.4	8.5	10.3	10.8	14	12.1	11.4	12	9.3	12
Net Profit Mgn % ⓘ	7.7	5.9	3.9	4.5	5.5	7.5	5.5	6.3	7.1	3.7	6.2
Debt to Equity ⓘ	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.1	0.1	0.1	-
Working Cap Days ⓘ	177	210	201	192	196	171	201	150	155	170	92
Cash Conv. Cycle ⓘ	57	72	84	72	76	64	87	84	100	102	62

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	39.3	-
TTM Sales (₹ Cr.)	76.2	-
BVPS (₹) ⓘ	473	-
Reserves (₹ Cr.) ⓘ	56	-
P/BV ⓘ	1.60	-
PE ⓘ	19.23	-

From the Market
52 Week Low / High (₹)	700.00 / 976.00
All Time Low / High (₹)	32.49 / 1303.00
Market Cap (₹ Cr.)	90.7
Equity (₹ Cr.)	1.2
Face Value (₹)	10
Industry PE ⓘ	42.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Mercury Laboratories - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	47.52	48.03	51.87	55.52	57.27	68.60	57.92	75.33	75.56	75.10
Operating Expenses ⓘ +	41.04	41.31	47.49	49.80	51.10	59.01	50.93	66.76	66.53	68.08
Manufacturing Costs	9.09	9.10	10.82	10.97	11.44	13.81	11.37	16.17	14.42	14.87
Material Costs	13.25	13.63	15.82	18.78	17.40	20.70	15.09	18.86	20.33	17.91
Employee Cost	6.99	6.73	7.13	7.61	9.12	9.62	12.31	13.92	14.18	16.30
Other Costs ⓘ	11.71	11.85	13.73	12.44	13.15	14.87	12.17	17.82	17.60	19.01
Operating Profit ⓘ	6.48	6.72	4.38	5.72	6.17	9.59	6.99	8.57	9.03	7.02
Operating Profit Margin (%)	13.6%	14.0%	8.4%	10.3%	10.8%	14.0%	12.1%	11.4%	12.0%	9.3%
Other Income ⓘ +	0.78	0.35	0.46	1.04	0.85	0.88	0.82	1.72	1.09	1.07
Exceptional Items ⓘ	0	0	0	0	0	0	0.13	0	0	0
Interest ⓘ	1.13	0.89	0.91	1.09	0.82	0.64	0.45	0.36	0.38	0.55
Depreciation ⓘ	1.18	1.29	1.47	1.63	1.87	1.92	2.45	2.48	2.82	2.88
Profit Before Tax ⓘ	4.94	4.89	2.46	4.05	4.33	7.91	5.03	7.44	6.92	4.66
Tax ⓘ	1.01	2.19	0.44	1.21	1.10	2.57	1.47	1.87	1.27	1.52
Profit After Tax	3.92	2.70	2.01	2.84	3.23	5.34	3.56	5.58	5.65	3.14
PAT Margin (%)	8.3%	5.6%	3.9%	5.1%	5.6%	7.8%	6.2%	7.4%	7.5%	4.2%
Adjusted EPS (₹)	32.7	22.5	16.8	23.6	26.9	44.5	29.7	46.5	47.1	26.2
Dividend Payout Ratio (%)	5%	7%	9%	6%	7%	8%	12%	8%	7%	13%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	21.85	24.47	26.35	28.97	31.98	36.89	40.31	45.63	50.84	53.57
Share Capital ⓘ	1.20	1.20	1.20	1.20	1.20	1.20	1.20	1.20	1.20	1.20
Reserves ⓘ	20.65	23.27	25.15	27.77	30.78	35.69	39.11	44.43	49.64	52.37
Debt +	6.57	7.42	9.69	8.50	6.33	6.24	5.07	5.31	5.32	3.70
Long Term Debt	2.84	7.42	9.69	8.50	6.33	6.24	2.49	2.42	2.86	3.04
Short Term Debt	3.73	0	0	0	0	0	2.58	2.89	2.46	0.66
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	7.59	10.34	8.90	11.67	8.43	11.78	6.87	6.38	5.18	9.83
Others Liabilities ⓘ	10.51	8.90	6.75	8.16	9.57	10.46	10.19	6.84	6.62	7.14
Total Liabilities ⓘ	46.51	51.14	51.70	57.30	56.30	65.37	62.43	64.16	67.96	74.24
Fixed Assets
Net Fixed Assets ⓘ +	18.57	18.39	20.78	24.39	23.66	26.36	25.82	24.26	24.03	24.64
Gross Block	25.34	26.44	30.21	35.44	36.58	41.15	43.04	43.96	45.68	48.32
Accumulated Depreciation	6.76	8.05	9.43	11.06	12.92	14.79	17.22	19.70	21.65	23.68
CWIP ⓘ	0	0.40	0.24	0	0	0	0	0.13	3.82	9.32
Investments ⓘ	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Inventories	6.43	7.61	7.69	6.78	5.51	5.16	6.78	6.90	6.21	7.21
Trade Receivables	13.41	17.53	14.72	19.29	18.14	22.54	16.74	21.37	21.85	25.74
Cash Equivalents	1.27	1.44	3.79	1.48	2.51	4.87	6.93	7.32	8.23	2.19
Others Assets ⓘ	6.82	5.77	4.47	5.35	6.48	6.45	6.15	4.18	3.82	5.13
Total Assets ⓘ	46.51	51.14	51.70	57.30	56.30	65.37	62.43	64.16	67.96	74.24

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0.10	1.92	4.97	5.22	5.49	8.21	5.19	2.45	8.23	4
PBT ⓘ	4.94	4.89	2.46	4.05	4.33	7.91	5.03	7.44	6.92	4.66
Adjustment ⓘ	2.32	2.18	2.46	2.72	2.69	2.56	2.88	2.85	3.20	3.48
Changes in Working Capital ⓘ	-4.81	-4.04	0.8	-0.52	-0.3	-0.89	-0.8	-6.73	-0.64	-1.75
Tax Paid ⓘ	-1.41	-1.12	-0.74	-1.03	-1.23	-1.37	-1.91	-1.10	-1.26	-2.39
Cash Flow From Investing Activity ⓘ +	-0.28	-1.50	-3.68	-4.99	-1.14	-4.62	-1.89	-1.06	-6.27	-9.04
Capex	-0.28	-1.50	-3.68	-4.99	-1.14	-4.62	-1.89	-1.06	-6.27	-9.04
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	0.47	-0.25	1.07	-2.54	-3.33	-1.24	-1.23	-1.01	-1.04	-0.99
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.91	-0.60	2.28	-1.19	-2.18	-0.09	-1.06	-0.06	0.44	0.18
Interest Paid ⓘ	0	-0.89	-0.91	-1.09	-0.82	-0.64	-0.45	-0.36	-0.38	-0.55
Dividend Paid ⓘ	-0.22	-0.22	-0.22	-0.22	-0.22	-0.42	-0.24	-0.42	-0.42	-0.42
Others ⓘ	-0.22	1.46	-0.08	-0.05	-0.12	-0.09	0.52	-0.17	-0.68	-0.20
Net Cash Flow ⓘ	0.09	0.17	2.36	-2.31	1.02	2.36	2.07	0.38	0.91	-6.03

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	19.62	11.67	7.92	10.26	10.59	15.5	9.23	12.98	11.72	6.02
ROCE (%)	21.58	18.93	9.89	13.77	13.25	20.56	12.26	16.19	13.61	9.14
Asset Turnover Ratio	1.13	1.03	1.02	1.02	1.01	1.13	0.91	1.19	1.14	1.06
PAT to CFO Conversion(x)	-0.03	0.71	2.47	1.84	1.7	1.54	1.46	0.44	1.46	1.27
Working Capital Days
Receivable Days	93	113	112	112	119	108	124	92	104	116
Inventory Days	39	51	53	48	39	28	38	33	32	33
Payable Days	207	240	222	200	211	178	226	128	104	153

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Mercury Laboratories Ltd FAQs

The current trading price of Mercury Laboratories on 16-Apr-2026 16:59 is ₹756.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 15-Apr-2026 the market cap of Mercury Laboratories stood at ₹90.73 Cr

The latest P/E ratio of Mercury Laboratories as of 15-Apr-2026 is 19.23.

The latest P/B ratio of Mercury Laboratories as of 15-Apr-2026 is 1.60.

The 52-week high of Mercury Laboratories is ₹976.0 and the 52-week low is ₹700.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Mercury Laboratories is ₹76.15 ( Cr.) .

About Mercury Laboratories Ltd

No data to display

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Mercury Laboratories Ltd (538964) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Mercury Laboratories Share Price